The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...

The state discovered a glitch in its Medicaid eligibility system. The problem, alleged in court testimony, led to new mothers ...

University of Pennsylvania Vice Provost of Global Initiatives Dr. Ezekiel Emanuel joins Andrea Mitchell to discuss President ...

The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...

Abortion is legal in all Australian states and territories. But the availability and cost of services depends on where you ...

Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration ...

As officials put the change in draft rules for 2026, the incoming president's Medicare agency pick might support it.

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic co ...

The AHA has long stated that while we appreciated CMS’ recognition of the wage index’s shortcomings, the agency should not ...

People with HIV will soon be permitted to receive transplanted kidneys and livers from donors who are also infected with the ...

The Biden administration’s proposal to expand coverage of weight-loss drugs to Medicare and Medicaid recipients is expensive ...